Positive allosteric modulators of GABAA receptors (GAMs) acting at specific subtypes of GABAA receptors effectively restore compromised spinal pain...
Array
(
[id_prestablog_news] => 661
[id_shop] => 1
[date] => 2015-03-01 00:00:00
[date_modification] => 2024-02-09 14:15:11
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 1292
[id_lang] => 2
[title] => GABAergic modulation in central sensitization in humans- a randomized placebo-co
[paragraph] => GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers.
[content] => Authors
Marie Besson, Alain Matthey, Youssef Daali, Antoine Poncet, Pascal Vuillemier, Michele Curatolo, Hanns Ulrich Zeilhofer, Jules Desmeules
Lab
University Hospital of Geneva, Geneva, Switzerland
Journal
Pain
Abstract
Positive allosteric modulators of GABAA receptors (GAMs) acting at specific subtypes of GABAA receptors effectively restore compromised spinal pain control in rodents. Studies addressing a similar antihyperalgesic effect in humans are sparse and are hampered by sedative effects of nonselective GAMs available for use in humans. We present results from a randomized controlled double-blind crossover study in 25 healthy volunteers, which addressed potential antihyperalgesic actions of clobazam (CBZ) and clonazepam (CLN) at mildly sedating equianticonvulsive doses. Clobazam was chosen because of its relatively low sedative properties and CLN because of its use in neuropathic pain. Tolterodine (TLT) was used as an active placebo. The primary outcome parameter was a change in the area of cutaneous UVB irradiation-induced secondary hyperalgesia (ASH), which was monitored for 8 hours after drug application. Sedative effects were assessed in parallel to antihyperalgesia. Compared with TLT, recovery from hyperalgesia was significantly faster in the CBZ and CLN groups (P = 0.009). At the time point of maximum effect, the rate of recovery from hyperalgesia was accelerated by CBZ and CLN, relative to placebo by 15.7% (95% confidence interval [CI] 0.8-30.5), P = 0.040, and 28.6% (95% CI 4.5-52.6), P = 0.022, respectively. Active compounds induced stronger sedation than placebo, but these differences disappeared 8 hours after drug application. We demonstrate here that GAMs effectively reduce central sensitization in healthy volunteers. These results provide proof-of-principle evidence supporting efficacy of GAMs as antihyperalgesic agents in humans and should stimulate further research on compounds with improved subtype specificity.
BIOSEB Instruments Used
Electronic Von Frey 4 (BIO-EVF4),Electronic Von Frey 5 with embedded camera (BIO-EVF5)
[meta_description] =>
[meta_keywords] => http://www.pubfacts.com/detail/25687539/GABAergic-modulation-in-central-sensitization-in-humans:-a-randomized-placebo-controlled-pharmacokin
[meta_title] =>
[link_rewrite] => gabaergic-modulation-in-central-sensitization-in-humans--a-randomized-placebo-controlled-pharmacokinetic-pharmacodynamic-study-comparing-clobazam-with-clonazepam-in-healthy-volunteers-
[actif_langue] => 1
[read] => 1039
[count_comments] => 0
[id] => 661
[categories] => Array
(
[36] => Array
(
[id_prestablog_categorie] => 36
[title] => Allodynie mécanique & Hyperalgésie
[link_rewrite] => Allodynie-mecanique-Hyperalgesie
)
[10] => Array
(
[id_prestablog_categorie] => 10
[title] => Douleur
[link_rewrite] => Douleur
)
[95] => Array
(
[id_prestablog_categorie] => 95
[title] => Pharmacologie
[link_rewrite] => Pharmacologie
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
[24] => Array
(
[id_prestablog_categorie] => 24
[title] => Thématiques transversales
[link_rewrite] => Thematiques-transversales
)
)
[authors] =>
[paragraph_crop] => GABAergic modulation in central sensitization in humans: a randomized placebo-controlled [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[1859] => Array
(
[name] => Von Frey Électronique - Sans Fil
[description_short] => Une solution rapide pour déterminer le seuil de sensibilité à la douleur mécanique chez les rongeurs (rats et souris). Maintenant en version sans-fil, pour être libéré des câbles!
Cet instrument électronique précis et simple d'utilisation est le test de référence pour vos recherches en analgésie, nociception, neuropathies et douleurs post-opératoires


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://preprod.bioseb.com/fr/douleur-allodyniehyperalgesie-mecanique/1859-electronic-von-frey-4.html
)
[1860] => Array
(
[name] => Von Frey Électronique 5 avec caméra intégrée
[description_short] =>
En tant que version électronique du classique esthésiomètre à filaments de Von Frey, la dernière évolution de l’instrument électronique Von Frey de Bioseb, conçu pour déterminer le seuil de sensibilité mécanique chez les rongeurs (rats et souris) par stimulation sous la patte, est un outil indispensable pour vos recherches sur l’hyperalgésie et l’allodynie. En mesurant et en enregistrant la force à laquelle l’animal présente un réflexe de retrait de la patte, il est possible d’étudier les pathologies liées à la réponse sensorielle ainsi qu’à l’hyper- ou l’hypoesthésie.
L'EVF5 intègre une caméra embarquée au niveau de la zone de stimulation et fonctionne avec un nouveau logiciel dédié révolutionnaire


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://preprod.bioseb.com/fr/douleur-allodyniehyperalgesie-mecanique/1860-electronic-von-frey-5-with-embedded-camera.html
)
)
)
1 En lire plus